EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 142 filers reported holding EPIZYME INC in Q4 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $165,000 | -54.0% | 143,759 | 0.0% | 0.29% | -10.0% |
| Q4 2021 | $359,000 | -76.1% | 143,759 | -51.1% | 0.32% | -72.8% |
| Q3 2021 | $1,504,000 | -38.4% | 293,759 | 0.0% | 1.18% | -20.0% |
| Q2 2021 | $2,441,000 | -4.6% | 293,759 | 0.0% | 1.47% | +13.9% |
| Q1 2021 | $2,559,000 | -19.8% | 293,759 | 0.0% | 1.29% | -23.1% |
| Q4 2020 | $3,190,000 | +9.7% | 293,759 | +20.5% | 1.68% | +104.9% |
| Q3 2020 | $2,908,000 | -25.7% | 243,759 | 0.0% | 0.82% | -33.6% |
| Q2 2020 | $3,915,000 | – | 243,759 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |